Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIb Clinical Trial to Evaluate the Efficacy and Safety of the Administration of RUTI® Immunotherapy With the Standard Treatment in Patients With Tuberculosis

NCT05455112 is registered in ClinicalTrials.gov with Archivel Farma S.L. as lead sponsor.

NCT NCT05455112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05455112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIb Clinical Trial to Evaluate the Efficacy and Safety of the Administration of RUTI® Immunotherapy With the Standard Treatment in Patients With Tuberculosis
Lead sponsor
Archivel Farma S.L.
Phase
Phase 2
Overall status
Completed
Start date
October 29, 2022
Completion date
October 30, 2024
Enrollment
41 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, pulmonary